Biogen (BIIB) Announces Approval of AVONEX PEN, Dose Titration Regimen from FDA

Go back to Biogen (BIIB) Announces Approval of AVONEX PEN, Dose Titration Regimen from FDA
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 214.35 --0 (-0%)
Previous Close $214.35    52 Week High $333.65 
Open $214.35    52 Week Low $223.02 
Day High $214.35    P/E 27.45 
Day Low $214.35    EPS $7.81 
Volume 86